Bioqual, Inc.
Bioqual, Inc. (BIOQ) Stock Competitors & Peer Comparison
See (BIOQ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOQ | $43.19 | +0.00% | 38.6M | 15.82 | $2.73 | +1.16% |
| GNTLF | $1.00 | +0.00% | 3.7T | -16.67 | -$0.06 | N/A |
| LZAGY | $67.43 | -1.37% | 47.4B | 52.31 | $1.29 | +0.63% |
| LZAGF | $690.00 | +0.00% | 45.9B | 52.08 | $12.92 | +0.71% |
| WUXAY | $13.32 | +5.71% | 35.5B | 18.79 | $0.67 | +2.53% |
| WUXIF | $7.34 | +0.00% | 20.2B | 13.59 | $0.54 | +2.50% |
| BMXMF | $144.20 | +0.00% | 17.6B | 35.43 | $4.21 | +0.66% |
| ERFSF | $76.70 | +0.66% | 13.7B | 29.28 | $2.63 | +0.87% |
| SKHCF | $18.39 | +0.00% | 9.3B | 25.38 | $0.74 | +3.74% |
| SKHHY | $18.28 | +1.11% | 8.9B | 24.79 | $0.73 | +3.73% |
Stock Comparison
BIOQ vs GNTLF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, GNTLF has a market cap of 3.7T. Regarding current trading prices, BIOQ is priced at $43.19, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, BIOQ's ROE is -0.06%, compared to GNTLF's ROE of -3.06%. Regarding short-term risk, BIOQ and GNTLF have similar daily volatility (0.00).Check GNTLF's competition here
BIOQ vs LZAGY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, LZAGY has a market cap of 47.4B. Regarding current trading prices, BIOQ is priced at $43.19, while LZAGY trades at $67.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas LZAGY's P/E ratio is 52.31. In terms of profitability, BIOQ's ROE is -0.06%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, BIOQ is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check LZAGY's competition here
BIOQ vs LZAGF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, LZAGF has a market cap of 45.9B. Regarding current trading prices, BIOQ is priced at $43.19, while LZAGF trades at $690.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas LZAGF's P/E ratio is 52.08. In terms of profitability, BIOQ's ROE is -0.06%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, BIOQ is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check LZAGF's competition here
BIOQ vs WUXAY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, WUXAY has a market cap of 35.5B. Regarding current trading prices, BIOQ is priced at $43.19, while WUXAY trades at $13.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas WUXAY's P/E ratio is 18.79. In terms of profitability, BIOQ's ROE is -0.06%, compared to WUXAY's ROE of +0.23%. Regarding short-term risk, BIOQ is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check WUXAY's competition here
BIOQ vs WUXIF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, WUXIF has a market cap of 20.2B. Regarding current trading prices, BIOQ is priced at $43.19, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, BIOQ's ROE is -0.06%, compared to WUXIF's ROE of +0.23%. Regarding short-term risk, BIOQ and WUXIF have similar daily volatility (0.00).Check WUXIF's competition here
BIOQ vs BMXMF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, BMXMF has a market cap of 17.6B. Regarding current trading prices, BIOQ is priced at $43.19, while BMXMF trades at $144.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas BMXMF's P/E ratio is 35.43. In terms of profitability, BIOQ's ROE is -0.06%, compared to BMXMF's ROE of +0.11%. Regarding short-term risk, BIOQ and BMXMF have similar daily volatility (0.00).Check BMXMF's competition here
BIOQ vs ERFSF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ERFSF has a market cap of 13.7B. Regarding current trading prices, BIOQ is priced at $43.19, while ERFSF trades at $76.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ERFSF's P/E ratio is 29.28. In terms of profitability, BIOQ's ROE is -0.06%, compared to ERFSF's ROE of +0.08%. Regarding short-term risk, BIOQ is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check ERFSF's competition here
BIOQ vs SKHCF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SKHCF has a market cap of 9.3B. Regarding current trading prices, BIOQ is priced at $43.19, while SKHCF trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SKHCF's P/E ratio is 25.38. In terms of profitability, BIOQ's ROE is -0.06%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, BIOQ and SKHCF have similar daily volatility (0.00).Check SKHCF's competition here
BIOQ vs SKHHY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SKHHY has a market cap of 8.9B. Regarding current trading prices, BIOQ is priced at $43.19, while SKHHY trades at $18.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SKHHY's P/E ratio is 24.79. In terms of profitability, BIOQ's ROE is -0.06%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, BIOQ is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check SKHHY's competition here
BIOQ vs HNGZY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, HNGZY has a market cap of 7.1B. Regarding current trading prices, BIOQ is priced at $43.19, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, BIOQ's ROE is -0.06%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, BIOQ and HNGZY have similar daily volatility (0.00).Check HNGZY's competition here
BIOQ vs DSRLF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, DSRLF has a market cap of 5.8B. Regarding current trading prices, BIOQ is priced at $43.19, while DSRLF trades at $107.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas DSRLF's P/E ratio is 26.79. In terms of profitability, BIOQ's ROE is -0.06%, compared to DSRLF's ROE of +0.12%. Regarding short-term risk, BIOQ and DSRLF have similar daily volatility (0.00).Check DSRLF's competition here
BIOQ vs VIMGF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, VIMGF has a market cap of 2.3B. Regarding current trading prices, BIOQ is priced at $43.19, while VIMGF trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas VIMGF's P/E ratio is 86.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, BIOQ and VIMGF have similar daily volatility (0.00).Check VIMGF's competition here
BIOQ vs MRCHF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MRCHF has a market cap of 1.3B. Regarding current trading prices, BIOQ is priced at $43.19, while MRCHF trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MRCHF's P/E ratio is 71.21. In terms of profitability, BIOQ's ROE is -0.06%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, BIOQ and MRCHF have similar daily volatility (0.00).Check MRCHF's competition here
BIOQ vs IDGXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, BIOQ is priced at $43.19, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to IDGXF's ROE of +0.19%. Regarding short-term risk, BIOQ and IDGXF have similar daily volatility (0.00).Check IDGXF's competition here
BIOQ vs CORBF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, CORBF has a market cap of 180.8M. Regarding current trading prices, BIOQ is priced at $43.19, while CORBF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas CORBF's P/E ratio is 3.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, BIOQ is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check CORBF's competition here
BIOQ vs EDTXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, EDTXF has a market cap of 173.6M. Regarding current trading prices, BIOQ is priced at $43.19, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas EDTXF's P/E ratio is -10.12. In terms of profitability, BIOQ's ROE is -0.06%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, BIOQ and EDTXF have similar daily volatility (0.00).Check EDTXF's competition here
BIOQ vs AMCY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, BIOQ is priced at $43.19, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas AMCY's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to AMCY's ROE of N/A. Regarding short-term risk, BIOQ and AMCY have similar daily volatility (0.00).Check AMCY's competition here
BIOQ vs NNGRF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, BIOQ is priced at $43.19, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, BIOQ's ROE is -0.06%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, BIOQ and NNGRF have similar daily volatility (0.00).Check NNGRF's competition here
BIOQ vs THOXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, BIOQ is priced at $43.19, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas THOXF's P/E ratio is -14.40. In terms of profitability, BIOQ's ROE is -0.06%, compared to THOXF's ROE of -1.09%. Regarding short-term risk, BIOQ and THOXF have similar daily volatility (0.00).Check THOXF's competition here
BIOQ vs DIUXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, BIOQ is priced at $43.19, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, BIOQ's ROE is -0.06%, compared to DIUXF's ROE of -0.04%. Regarding short-term risk, BIOQ and DIUXF have similar daily volatility (0.00).Check DIUXF's competition here
BIOQ vs PFGTF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, PFGTF has a market cap of 80.1M. Regarding current trading prices, BIOQ is priced at $43.19, while PFGTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas PFGTF's P/E ratio is -4.93. In terms of profitability, BIOQ's ROE is -0.06%, compared to PFGTF's ROE of -0.86%. Regarding short-term risk, BIOQ and PFGTF have similar daily volatility (0.00).Check PFGTF's competition here
BIOQ vs TIHE Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, BIOQ is priced at $43.19, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas TIHE's P/E ratio is 0.32. In terms of profitability, BIOQ's ROE is -0.06%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, BIOQ and TIHE have similar daily volatility (0.00).Check TIHE's competition here
BIOQ vs BIOGF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, BIOQ is priced at $43.19, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, BIOQ's ROE is -0.06%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, BIOQ and BIOGF have similar daily volatility (0.00).Check BIOGF's competition here
BIOQ vs PCNEF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, BIOQ is priced at $43.19, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, BIOQ's ROE is -0.06%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, BIOQ and PCNEF have similar daily volatility (0.00).Check PCNEF's competition here
BIOQ vs LDXHF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, LDXHF has a market cap of 48.7M. Regarding current trading prices, BIOQ is priced at $43.19, while LDXHF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas LDXHF's P/E ratio is -6.50. In terms of profitability, BIOQ's ROE is -0.06%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, BIOQ and LDXHF have similar daily volatility (0.00).Check LDXHF's competition here
BIOQ vs CLIFF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, BIOQ is priced at $43.19, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, BIOQ's ROE is -0.06%, compared to CLIFF's ROE of -0.10%. Regarding short-term risk, BIOQ and CLIFF have similar daily volatility (0.00).Check CLIFF's competition here
BIOQ vs SNANF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SNANF has a market cap of 42.1M. Regarding current trading prices, BIOQ is priced at $43.19, while SNANF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SNANF's P/E ratio is -19.05. In terms of profitability, BIOQ's ROE is -0.06%, compared to SNANF's ROE of -2.31%. Regarding short-term risk, BIOQ and SNANF have similar daily volatility (0.00).Check SNANF's competition here
BIOQ vs ANPCF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ANPCF has a market cap of 34.2M. Regarding current trading prices, BIOQ is priced at $43.19, while ANPCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ANPCF's P/E ratio is -1.77. In terms of profitability, BIOQ's ROE is -0.06%, compared to ANPCF's ROE of -0.66%. Regarding short-term risk, BIOQ and ANPCF have similar daily volatility (0.00).Check ANPCF's competition here
BIOQ vs BMKDF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, BMKDF has a market cap of 26.4M. Regarding current trading prices, BIOQ is priced at $43.19, while BMKDF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas BMKDF's P/E ratio is -25.10. In terms of profitability, BIOQ's ROE is -0.06%, compared to BMKDF's ROE of +7.41%. Regarding short-term risk, BIOQ is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check BMKDF's competition here
BIOQ vs ANPCY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ANPCY has a market cap of 24.3M. Regarding current trading prices, BIOQ is priced at $43.19, while ANPCY trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ANPCY's P/E ratio is -1.18. In terms of profitability, BIOQ's ROE is -0.06%, compared to ANPCY's ROE of -0.66%. Regarding short-term risk, BIOQ is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check ANPCY's competition here
BIOQ vs IMMVF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, BIOQ is priced at $43.19, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, BIOQ's ROE is -0.06%, compared to IMMVF's ROE of -5.30%. Regarding short-term risk, BIOQ and IMMVF have similar daily volatility (0.00).Check IMMVF's competition here
BIOQ vs PCHM Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, PCHM has a market cap of 21.7M. Regarding current trading prices, BIOQ is priced at $43.19, while PCHM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas PCHM's P/E ratio is -0.02. In terms of profitability, BIOQ's ROE is -0.06%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, BIOQ is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check PCHM's competition here
BIOQ vs VILGF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, BIOQ is priced at $43.19, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas VILGF's P/E ratio is -0.30. In terms of profitability, BIOQ's ROE is -0.06%, compared to VILGF's ROE of N/A. Regarding short-term risk, BIOQ and VILGF have similar daily volatility (0.00).Check VILGF's competition here
BIOQ vs VRCDF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, VRCDF has a market cap of 15.1M. Regarding current trading prices, BIOQ is priced at $43.19, while VRCDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas VRCDF's P/E ratio is -0.33. In terms of profitability, BIOQ's ROE is -0.06%, compared to VRCDF's ROE of -0.76%. Regarding short-term risk, BIOQ and VRCDF have similar daily volatility (0.00).Check VRCDF's competition here
BIOQ vs IZOZF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IZOZF has a market cap of 14.4M. Regarding current trading prices, BIOQ is priced at $43.19, while IZOZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IZOZF's P/E ratio is -7.92. In terms of profitability, BIOQ's ROE is -0.06%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, BIOQ is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check IZOZF's competition here
BIOQ vs ABDXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, BIOQ is priced at $43.19, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, BIOQ's ROE is -0.06%, compared to ABDXF's ROE of -0.48%. Regarding short-term risk, BIOQ and ABDXF have similar daily volatility (0.00).Check ABDXF's competition here
BIOQ vs PMSNF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, PMSNF has a market cap of 11.8M. Regarding current trading prices, BIOQ is priced at $43.19, while PMSNF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas PMSNF's P/E ratio is -2.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, BIOQ and PMSNF have similar daily volatility (0.00).Check PMSNF's competition here
BIOQ vs MXDHF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, BIOQ is priced at $43.19, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, BIOQ's ROE is -0.06%, compared to MXDHF's ROE of -4.78%. Regarding short-term risk, BIOQ and MXDHF have similar daily volatility (0.00).Check MXDHF's competition here
BIOQ vs SQIDF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, BIOQ is priced at $43.19, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, BIOQ's ROE is -0.06%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, BIOQ is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check SQIDF's competition here
BIOQ vs TDSGF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, TDSGF has a market cap of 5.9M. Regarding current trading prices, BIOQ is priced at $43.19, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas TDSGF's P/E ratio is -2.95. In terms of profitability, BIOQ's ROE is -0.06%, compared to TDSGF's ROE of -2.99%. Regarding short-term risk, BIOQ and TDSGF have similar daily volatility (0.00).Check TDSGF's competition here
BIOQ vs AVCRF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, AVCRF has a market cap of 5.9M. Regarding current trading prices, BIOQ is priced at $43.19, while AVCRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas AVCRF's P/E ratio is -5.79. In terms of profitability, BIOQ's ROE is -0.06%, compared to AVCRF's ROE of -0.42%. Regarding short-term risk, BIOQ is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check AVCRF's competition here
BIOQ vs RNVA Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, BIOQ is priced at $43.19, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas RNVA's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, BIOQ and RNVA have similar daily volatility (0.00).Check RNVA's competition here
BIOQ vs IDXG Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IDXG has a market cap of 3.8M. Regarding current trading prices, BIOQ is priced at $43.19, while IDXG trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IDXG's P/E ratio is 3.04. In terms of profitability, BIOQ's ROE is -0.06%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, BIOQ is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check IDXG's competition here
BIOQ vs JMPHF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, JMPHF has a market cap of 3.6M. Regarding current trading prices, BIOQ is priced at $43.19, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, BIOQ's ROE is -0.06%, compared to JMPHF's ROE of +0.43%. Regarding short-term risk, BIOQ and JMPHF have similar daily volatility (0.00).Check JMPHF's competition here
BIOQ vs IBXXF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IBXXF has a market cap of 3M. Regarding current trading prices, BIOQ is priced at $43.19, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IBXXF's P/E ratio is -0.50. In terms of profitability, BIOQ's ROE is -0.06%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, BIOQ and IBXXF have similar daily volatility (0.00).Check IBXXF's competition here
BIOQ vs SLDX Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SLDX has a market cap of 2.9M. Regarding current trading prices, BIOQ is priced at $43.19, while SLDX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SLDX's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, BIOQ and SLDX have similar daily volatility (0.00).Check SLDX's competition here
BIOQ vs SZLSF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SZLSF has a market cap of 2.3M. Regarding current trading prices, BIOQ is priced at $43.19, while SZLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SZLSF's P/E ratio is -0.16. In terms of profitability, BIOQ's ROE is -0.06%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, BIOQ and SZLSF have similar daily volatility (0.00).Check SZLSF's competition here
BIOQ vs IDTA Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IDTA has a market cap of 2M. Regarding current trading prices, BIOQ is priced at $43.19, while IDTA trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IDTA's P/E ratio is 4.88. In terms of profitability, BIOQ's ROE is -0.06%, compared to IDTA's ROE of +0.04%. Regarding short-term risk, BIOQ and IDTA have similar daily volatility (0.00).Check IDTA's competition here
BIOQ vs ICBU Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ICBU has a market cap of 1.9M. Regarding current trading prices, BIOQ is priced at $43.19, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ICBU's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, BIOQ is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check ICBU's competition here
BIOQ vs IVRO Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IVRO has a market cap of 1.7M. Regarding current trading prices, BIOQ is priced at $43.19, while IVRO trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IVRO's P/E ratio is -0.77. In terms of profitability, BIOQ's ROE is -0.06%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, BIOQ and IVRO have similar daily volatility (0.00).Check IVRO's competition here
BIOQ vs NSTM Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, BIOQ is priced at $43.19, while NSTM trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas NSTM's P/E ratio is -0.42. In terms of profitability, BIOQ's ROE is -0.06%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, BIOQ and NSTM have similar daily volatility (0.00).Check NSTM's competition here
BIOQ vs DIGP Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, BIOQ is priced at $43.19, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas DIGP's P/E ratio is -1.04. In terms of profitability, BIOQ's ROE is -0.06%, compared to DIGP's ROE of +2.94%. Regarding short-term risk, BIOQ is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check DIGP's competition here
BIOQ vs EPGNF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, EPGNF has a market cap of 982.2K. Regarding current trading prices, BIOQ is priced at $43.19, while EPGNF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas EPGNF's P/E ratio is -0.05. In terms of profitability, BIOQ's ROE is -0.06%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, BIOQ and EPGNF have similar daily volatility (0.00).Check EPGNF's competition here
BIOQ vs SCRSF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, SCRSF has a market cap of 901.2K. Regarding current trading prices, BIOQ is priced at $43.19, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas SCRSF's P/E ratio is -0.30. In terms of profitability, BIOQ's ROE is -0.06%, compared to SCRSF's ROE of +1.97%. Regarding short-term risk, BIOQ and SCRSF have similar daily volatility (0.00).Check SCRSF's competition here
BIOQ vs RSHN Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, BIOQ is priced at $43.19, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas RSHN's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, BIOQ and RSHN have similar daily volatility (0.00).Check RSHN's competition here
BIOQ vs MBGNF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, BIOQ is priced at $43.19, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, BIOQ and MBGNF have similar daily volatility (0.00).Check MBGNF's competition here
BIOQ vs NVTAQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, BIOQ is priced at $43.19, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, BIOQ is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check NVTAQ's competition here
BIOQ vs ARYC Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, BIOQ is priced at $43.19, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ARYC's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, BIOQ and ARYC have similar daily volatility (0.00).Check ARYC's competition here
BIOQ vs HCLC Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, BIOQ is priced at $43.19, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas HCLC's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, BIOQ and HCLC have similar daily volatility (0.00).Check HCLC's competition here
BIOQ vs MEDVF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, BIOQ is priced at $43.19, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, BIOQ's ROE is -0.06%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, BIOQ and MEDVF have similar daily volatility (0.00).Check MEDVF's competition here
BIOQ vs CHHL Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, BIOQ is priced at $43.19, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas CHHL's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, BIOQ and CHHL have similar daily volatility (0.00).Check CHHL's competition here
BIOQ vs IHTI Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, BIOQ is priced at $43.19, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas IHTI's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, BIOQ and IHTI have similar daily volatility (0.00).Check IHTI's competition here
BIOQ vs MEDD Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, BIOQ is priced at $43.19, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MEDD's P/E ratio is -0.01. In terms of profitability, BIOQ's ROE is -0.06%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, BIOQ and MEDD have similar daily volatility (0.00).Check MEDD's competition here
BIOQ vs TOMDF Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, BIOQ is priced at $43.19, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas TOMDF's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, BIOQ and TOMDF have similar daily volatility (0.00).Check TOMDF's competition here
BIOQ vs CGNH Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, BIOQ is priced at $43.19, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas CGNH's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, BIOQ and CGNH have similar daily volatility (0.00).Check CGNH's competition here
BIOQ vs ABMC Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, BIOQ is priced at $43.19, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ABMC's P/E ratio is 0.01. In terms of profitability, BIOQ's ROE is -0.06%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, BIOQ and ABMC have similar daily volatility (0.00).Check ABMC's competition here
BIOQ vs RGDXQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, BIOQ is priced at $43.19, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, BIOQ and RGDXQ have similar daily volatility (0.00).Check RGDXQ's competition here
BIOQ vs DMTKQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, BIOQ is priced at $43.19, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to DMTKQ's ROE of -1.06%. Regarding short-term risk, BIOQ and DMTKQ have similar daily volatility (0.00).Check DMTKQ's competition here
BIOQ vs GWHP Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, BIOQ is priced at $43.19, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas GWHP's P/E ratio is -0.00. In terms of profitability, BIOQ's ROE is -0.06%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, BIOQ is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for BIOQ.Check GWHP's competition here
BIOQ vs CYPS Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, CYPS has a market cap of 811. Regarding current trading prices, BIOQ is priced at $43.19, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas CYPS's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to CYPS's ROE of N/A. Regarding short-term risk, BIOQ and CYPS have similar daily volatility (0.00).Check CYPS's competition here
BIOQ vs ROSGQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, BIOQ is priced at $43.19, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, BIOQ and ROSGQ have similar daily volatility (0.00).Check ROSGQ's competition here
BIOQ vs BIOCQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, BIOQ is priced at $43.19, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, BIOQ and BIOCQ have similar daily volatility (0.00).Check BIOCQ's competition here
BIOQ vs HTGMQ Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, BIOQ is priced at $43.19, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, BIOQ and HTGMQ have similar daily volatility (0.00).Check HTGMQ's competition here
BIOQ vs OPGX Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, OPGX has a market cap of 17. Regarding current trading prices, BIOQ is priced at $43.19, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas OPGX's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, BIOQ and OPGX have similar daily volatility (0.00).Check OPGX's competition here
BIOQ vs AGHC Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, AGHC has a market cap of 0. Regarding current trading prices, BIOQ is priced at $43.19, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas AGHC's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, BIOQ and AGHC have similar daily volatility (0.00).Check AGHC's competition here
BIOQ vs BGNX Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, BGNX has a market cap of 0. Regarding current trading prices, BIOQ is priced at $43.19, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas BGNX's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to BGNX's ROE of N/A. Regarding short-term risk, BIOQ and BGNX have similar daily volatility (0.00).Check BGNX's competition here
BIOQ vs EPGNY Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, BIOQ is priced at $43.19, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, BIOQ's ROE is -0.06%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, BIOQ and EPGNY have similar daily volatility (0.00).Check EPGNY's competition here
BIOQ vs MRPS Comparison August 2025
BIOQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOQ stands at 38.6M. In comparison, MRPS has a market cap of 0. Regarding current trading prices, BIOQ is priced at $43.19, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOQ currently has a P/E ratio of 15.82, whereas MRPS's P/E ratio is N/A. In terms of profitability, BIOQ's ROE is -0.06%, compared to MRPS's ROE of N/A. Regarding short-term risk, BIOQ and MRPS have similar daily volatility (0.00).Check MRPS's competition here